Linked Life Data

12174523

Source:http://linkedlifedata.com/resource/pubmed/id/12174523

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2002-8-14
pubmed:abstractText
One of the most compelling questions a cardiologist (and, for that matter, any clinician) has to face involves choosing the optimal management strategy for their patients. One of the best sources of information about therapy is the randomized controlled trial, which, despite several significant shortcomings, is considered to be the gold standard in studies about therapeutics and prevention. The methodologic quality of therapeutic trials is highly variable and--as already discussed in previous articles--in order to be useful they have to be critically appraised in terms of the validity of their results, their importance, and their applicability to the individual patient. In a previous article published in the Journal, critical appraisal of evidence in therapy was presented, concerning the issue of validity. In this article, we will introduce a critical appraisal of the importance of the results obtained through randomized clinical trials, and in the final article we will discuss their applicability.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0870-2551
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
613-26
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Basics of methodologic analysis of therapeutic trials. Part II: Importance of the results.
pubmed:affiliation
Serviço de Medicina I, Hospital de Egas Moniz, Lisboa.
pubmed:publicationType
Journal Article